Home > Insider Trading > Filing (0001179110-20-001763)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1730430	Kiniksa Pharmaceuticals Ltd.	KNSA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1741533	F. John Paolini	C/O Kiniksa Pharmaceuticals, Ltd. Clarendon House 2 Church Street Hamilton D0 HM11	Svp & Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Shares	Acquisiton	2020-02-13	10,277	$3.80	28,277	No	4	M	Direct
Class A Common Shares	Disposition	2020-02-13	10,277	$18.29	18,000	No	4	S	Direct
Class A Common Shares	Acquisiton	2020-02-14	1,039	$3.80	19,039	No	4	M	Direct
Class A Common Shares	Disposition	2020-02-14	1,039	$18.33	18,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Shares	Share Option	Disposition	2020-02-13	10,277	$0.00	10,277	$3.80
Class A Common Shares	Share Option	Disposition	2020-02-14	1,039	$0.00	1,039	$3.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
99,861		2027-06-28	No	4	M	Direct
98,822		2027-06-28	No	4	M	Direct

Footnotes

The Share Option exercise and sale of Class A Common Shares ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 16, 2019.
The Share Option granted the reporting person an option to purchase 110,138 Shares. 25% of such Shares vested and became exercisable on June 28, 2018, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $18.26 to $18.44. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $18.26 to $18.47. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.